Gastrointestinal symptoms and Coronavirus disease 2019: A case-control study from the United States
Fecha
2020Autor
Nobel, Yael R.
Phipps, Meaghan
Zucker, Jason
Lebwohl, Benjamin
Wang, Timothy C.
Sobieszczyk, Magdalena E.
Freedberg, Daniel E.
Documentos PDF
Imagenes y Videos
Resumen
Coronavirus disease 2019 (COVID-19) is a pandemic
characterized by a high fatality rate.1 The incidence
of COVID-19 has risen dramatically in the United States
since March 2020, with the highest number of cases in the
country present in New York City.2 As health care systems
rise to the challenge of unprecedented demands, there is an
urgent need to characterize the spectrum of clinical presentations of this disease to allow early identification, isolation,
and triage of affected patients.
Although fever, cough, and shortness of breath are among
the most common presenting symptoms, gastrointestinal
symptoms are increasingly recognized among patients with
COVID-19.3–7 This case-control study aimed to describe
gastrointestinal symptomatology—including diarrhea and
nausea/vomiting—in US patients with COVID-19 compared
to patients presenting under similar circumstances who
tested negative for COVID-19. The secondary aims were to
characterize the associations of gastrointestinal symptoms
with total illness duration and early clinical outcomes.
Palabras clave
Gastrointestinal symptoms; Coronavirus disease 2019; COVID-19; SARS-CoV-2; Diarrhea; Nausea; VomitingEnlace al recurso
https://doi.org/10.1053/j.gastro.2020.04.017Colecciones
Estadísticas Google Analytics
Comentarios
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.